Page 27 - ITPS-6-2

INNOSC Theranostics and
Pharmacological Sciences TDM of imipramine: Correlation and case study

24. Tofranil-PMTM (Imipramine Pamoate), n.d., Available 13: 819–823.
from: https://www.accessdata.fda.gov/drugsatfda_docs/ 28. Rubio MA, Bartolomei M, Perez-Castrillon JL, 1998,
label/2014/017090s078lbl.pdf [Last access on 2023 May 20]. Acute hepatitis associated with imipramine therapy. Ann
25. Schatzberg AF, Cole JO, DeBattista C, 2010, Manual of Pharmacother, 32: 1263–1265.
Clinical Psychopharmacology. 7 ed. Washington, D.C.: 29. Himmelhoch JM, Neil JF, 1982, Hypomania induced by
th
American Psychiatric Publishing, Inc. imipramine. Am J Psychiatry, 139: 1221–1222.
26. Leinonen E, Skott A, Lundstrom K, 1980, Effects of 30. Lipschitz DA, Mitchell JE, Krall RA, 1976, Imipramine and
phenobarbitone and cigarette smoking on the metabolism of urinary retention. J Am Med Assoc, 235: 1497.
imipramine and nortriptyline in man. Eur J Clin Pharmacol,
18: 377–384. 31. Wijdicks EF, Scott JP, 1994, Imipramine-induced
hyponatremia. Neurology, 44: 330–331.
https://doi.org/10.1007/BF00540902
32. Sachdeva M, Kaur T, Ahmed R S, 2015, Pharmacogenetics
27. Hulten BA, Adams RD, Schwegler JC, 1984, Imipramine of cytochrome P450 enzymes of imipramine metabolism:
overdose: Treatment and clinical course. Ann Emerg Med, A review. Pharmacol Rep, 67: 230–238.

Volume 6 Issue 2 (2023) 7 https://doi.org/10.36922/itps.0505